Regulatory Affairs Revisited: Practitioner or Professional?

Author： Gundersen L.E.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.17, Iss.3-4, 2003-01, pp. : 117-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Veterans Affairs Diabetes Trial vindicates rosiglitazone?

By  

Inpharma, Vol. 1, Iss. 1643, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

You've Found a Safety Signal - Now What?: Regulatory Implications of Industry Signal Detection Activities

By Kahn Sidney N.  

Drug Safety, Vol. 30, Iss. 7, 2007-01 ,pp. : 615-616

Adis International

Access to resources Recommend Favorite

Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows?

By GarrisonJr Louis P.  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 855-865

Adis International

Access to resources Recommend Favorite

Regulatory Sub-Classification of Phase I Studies: `Phase 0.5' ?

By Fox Anthony W.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 1, 2005-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Adherence to Medicines in the Older-Aged with Chronic Conditions: Does Intervention by an Allied Health Professional Help?

By Doggrell Sheila A.  

Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. : 239-254

Adis International

Access to resources Recommend Favorite